Skip to main content
. 2016 Apr 18;9:2287–2295. doi: 10.2147/OTT.S97583

Figure 1.

Figure 1

The proportion of trastuzumab+ (combination of trastuzumab and chemotherapy) patients out of all HER2-positive (HER2+) patients.

Note: The number of HER2+ patients and patients treated with trastuzumab (trastuzumab+) increased gradually each year from 2007 to 2011.

Abbreviation: HER2, human epidermal growth factor receptor 2.